Inventor · disambiguated record
Liang Qu
Also filed as: QU LIANG
2 granted patents·20 pending applications·1 citations·filing 2011–2024
36Inventor score
Files withUNIV BEIJING9BEIGENE SWITZERLAND GMBH6BEIGENE LTD1BEIJING TUO JIE BIOPHARMACEUTICAL CO LTD1BIGNER DARELL D1
Top patents by PatentIndex Score
22 records- 0183US11661596B2Targeted RNA editing by leveraging endogenous ADAR using engineered RNAsUNIV BEIJING·Filed 2022·Granted May 30, 2023·1 cites·25 claims
- 0271US2023365962A1Targeted rna editing by leveraging endogenous adar using engineered rnasUNIV BEIJING·Filed 2023·Application pending·0 cites
- 0366US2025075002A1MUC1 and CD16A Antibodies and Methods of UseBEIGENE SWITZERLAND GMBH·Filed 2024·Application pending·0 cites
- 0464US2025154279A1Anti-gpc3 and anti-cd137 multispecific antibodies and methods of useBEIGENE LTD·Filed 2024·Application pending·0 cites
- 0563US2024209106A1Anti-cd137 antibodies and methods of useBEIGENE SWITZERLAND GMBH·Filed 2023·Application pending·0 cites
- 0663US2024190989A1Anti-cea and anti-cd137 multispecific antibodies and methods of useBEIGENE SWITZERLAND GMBH·Filed 2023·Application pending·0 cites
- 0763US2024190990A1Anti-cea antibodies and methods of useBEIGENE SWITZERLAND GMBH·Filed 2023·Application pending·0 cites
- 0862US2024209113A1Anti-gpc3 and anti-cd137 multispecific antibodies and methods of useBEIGENE SWITZERLAND GMBH·Filed 2023·Application pending·0 cites
- 0960US2025115677A1Anti-CEA Antibody Drug Conjugates and Methods of UseBEIGENE SWITZERLAND GMBH·Filed 2024·Application pending·0 cites
- 1060US2025082746A1Circular rna vaccines against sars-cov-2 variants and methods of use thereofUNIV BEIJING·Filed 2023·Application pending·0 cites
- 1158US2022243194A1Targeted rna editing by leveraging endogenous adar using engineered rnasUNIV BEIJING·Filed 2020·Application pending·0 cites
- 1255US2025108134A1Circular rna vaccines and methods of use thereofBeijing Changping Laboratory·Filed 2023·Application pending·0 cites
- 1355US2025051816A1Single-pot methods for producing circular rnasUNIV BEIJING·Filed 2022·Application pending·0 cites
- 1455US2021310026A1Methods and compositions for editing rnasUNIV BEIJING·Filed 2021·Application pending·0 cites
- 1551US2021355494A1Methods and compositions for editing rnasUNIV BEIJING·Filed 2019·Application pending·0 cites
- 1650US11702658B2Methods and compositions for editing RNAsEDIGENE THERAPEUTICS BEIJING INC·Filed 2021·Granted Jul 18, 2023·0 cites·16 claims
- 1750US2024279298A1Glucagon analog and medical use thereofBEIJING TUO JIE BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1848US2024309368A1Targeted rna editing by leveraging endogenous adar using engineered rnasUNIV BEIJING·Filed 2021·Application pending·0 cites
- 1947US2023346921A1Circular rna vaccines and methods of use thereofUNIV BEIJING·Filed 2021·Application pending·0 cites
- 2044US2022307020A1Methods and compositions for editing rnasEDIGENE INC·Filed 2020·Application pending·0 cites
- 2134US2013217085A1Methods for improving fermentation yield of polyunsaturated fatty acidsHUANG HE·Filed 2011·Application pending·0 cites
- 2228US2016032007A1Human Antibody Fragments Against Chondroitin Sulfate Proteoglycan 4 (CSPG4)BIGNER DARELL D·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Liang Qu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →